Point72 Hong Kong LTD Supernus Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$28.79 - $35.41 $3,310 - $4,072
115 New
115 $4,000
Q1 2022

May 16, 2022
SELL
$28.51 - $32.9 $3,848 - $4,441
-135 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$26.37 - $34.22 $3,559 - $4,619
135 New
135 $4,000
Q3 2020

Nov 16, 2020
SELL
$20.2 - $25.05 $24,543 - $30,435
-1,215 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$17.09 - $24.89 $20,764 - $30,241
1,215 New
1,215 $29,000
Q1 2020

May 15, 2020
SELL
$14.45 - $24.69 $2,398 - $4,098
-166 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.93 - $29.13 $3,308 - $4,835
166 New
166 $4,000
Q3 2019

Nov 14, 2019
SELL
$25.47 - $33.37 $43,095 - $56,462
-1,692 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$29.96 - $38.87 $38,738 - $50,258
1,293 Added 324.06%
1,692 $56,000
Q1 2019

May 15, 2019
BUY
$32.77 - $41.99 $12,092 - $15,494
369 Added 1230.0%
399 $14,000
Q4 2018

Feb 14, 2019
BUY
$30.84 - $49.51 $925 - $1,485
30 New
30 $1,000
Q3 2018

Nov 14, 2018
SELL
$42.7 - $56.55 $1,366 - $1,809
-32 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$44.1 - $59.85 $1,411 - $1,915
32 New
32 $2,000
Q1 2018

May 15, 2018
SELL
$37.15 - $46.9 $10,550 - $13,319
-284 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$36.4 - $42.6 $10,337 - $12,098
284
284 $11,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email